• DAPI (hydrochloride): DNA Readouts in PDOs

  2026-08-18

  DAPI (hydrochloride) provides a practical DNA readout for pancreatic ductal organoids, but its greatest value depends on matching staining mode to the biological question. This guide connects minor-groove binding, organoid assay design, cell-cycle interpretation, and the findings of a recent high-efficiency PDO study.

• YAP-TEAD Super-Enhancers in Ectoderm Fate

  2026-08-17

  Wang et al. show that YAP-TEAD activity regulates the early establishment of super-enhancers during pluripotent stem cell differentiation toward surface ectoderm. By combining three-dimensional genomic analysis with locus-specific CRISPR-dCas9 perturbation and transcription-factor experiments, the study connects enhancer architecture to lineage commitment and epithelial regeneration research.

• Merimepodib (VX-497) for IMPDH Research

  2026-08-17

  Merimepodib (VX-497) connects guanine nucleotide depletion with practical cancer, immunology, and host-directed antiviral assays. This workflow-focused guide explains how to prepare the compound, confirm IMPDH-dependent effects, reproduce the PEDV research logic, and troubleshoot weak or inconsistent phenotypes.

• EPZ-6438 EZH2 Inhibitor Workflow Guide

  2026-08-16

  EPZ-6438 provides a selective pharmacological route to suppress EZH2-driven H3K27me3, enabling target-engagement, proliferation, and resistance studies across cancer models. This guide translates its biochemical profile into practical workflows and extends recent melanoma findings into time-resolved combination assays.

• ATS-9R and the Future of Adipose Gene Delivery

  2026-08-15

  A translational perspective on how ATS-9R combines Prohibitin-mediated endocytosis with nona-arginine cargo condensation to advance gene silencing in adipocytes, adipose tissue macrophages, obesity-associated inflammation research, and metabolic disease models.

• Baricitinib (LY3009104) for JAK-STAT Research

  2026-08-15

  Baricitinib (LY3009104) provides a practical perturbation tool for testing JAK1/2-dependent cytokine signaling alongside spatial proteomics. This article translates PD-L1–IL-6 findings in primary sclerosing cholangitis into cell-based, co-culture, and preclinical assay workflows with built-in optimization controls.

• P. aeruginosa C/T Resistance: PKPD Study

  2026-08-14

  Deroche and colleagues used engineered mutants, clinical isolates, sequential time-kill experiments, and semi-mechanistic PKPD modeling to separate immediate from adaptive ceftolozane-tazobactam resistance. The study shows that ampC and ampD mutations have distinct, time-dependent effects and that their combination can markedly reduce susceptibility while altering imipenem response.

• SHH, FGF10, and Species-Specific Penile Development

  2026-08-14

  A 2025 Cells study shows that species-specific differences in prepuce and urethral groove formation are associated with differential Shh, Fgf10, and Fgfr2 expression in developing genital tubercles. Comparative gene expression, tissue culture, and protein perturbation experiments provide a mechanistic framework for interpreting mouse models of human penile development and congenital malformation research.

• Caspase-3 Colorimetric Assay Kit in ER Stress

  2026-08-13

  The Caspase-3 Colorimetric Assay Kit provides a practical way to test whether ER stress and inflammatory activation culminate in executioner-caspase activity. This article connects K2008 assay design with the IgSF6 intestinal macrophage study while defining controls, interpretive limits, and complementary readouts.

• CCT007093: A Mechanism-First PPM1D Assay Guide

  2026-08-13

  Explore how CCT007093 functions as a PPM1D inhibitor and how to interpret its effects across p38 signaling, breast cancer, and renal injury models. This mechanism-first guide emphasizes assay design, controls, model selection, and the limits of translating pathway observations into target-specific conclusions.

• NU6300 Targets Gasdermin D at Cysteine-191

  2026-08-12

  Jiang et al. identify NU6300 as a covalent gasdermin D inhibitor that targets cysteine-191 and blocks both gasdermin D cleavage and palmitoylation. The study links this mechanism to impaired membrane localization, oligomerization, and pyroptosis, while showing protective effects in experimental colitis and sepsis models.

• JNJ-10198409: PDGF Receptor Inhibition Workflows

  2026-08-12

  JNJ-10198409 provides a nanomolar starting point for dissecting PDGF-BB-driven kinase signaling, proliferation, migration, and angiogenesis-related phenotypes. This practical guide translates its ATP-site mechanism into dose-response, pathway-engagement, and troubleshooting workflows for cancer biology and fibrotic disorder research.

• PR-619: Deubiquitylating Enzymes Inhibitor Guide

  2026-08-11

  PR-619 is a reversible, cell-permeable DUB inhibitor for separating ubiquitination changes from direct proteasome blockade. This guide covers practical dosing, autophagy and cancer workflows, neurodegeneration applications, and troubleshooting for more interpretable cell-based assays.

• Olive Oil Polyphenols in Cardiovascular Protection

  2026-08-10

  Boumezough et al. compare standard and naturally high-phenolic extra virgin olive oil extracts with hydroxytyrosol and tyrosol to connect polyphenol concentration with antioxidant, anti-inflammatory, and cholesterol-efflux effects. The findings provide a useful cellular framework for studying oxidative stress modulation and atheroprotective mechanisms, while also emphasizing the limits of extrapolating in vitro activity to clinical cardiovascular benefit.

• KNUCKLES Controls Floral Meristem Termination

  2026-08-09

  This Arabidopsis study identifies KNUCKLES as an epigenetic coordinator of floral meristem termination, linking repression of WUS and CLV3 with direct control of PIN1 and IPT7. The findings establish how auxin distribution and cytokinin activity are jointly adjusted to convert a transient floral meristem into a determinate structure.

443 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page